Neurocrine Biosciences, Inc. (LON: 0K6R)
London flag London · Delayed Price · Currency is GBP · Price in USD
152.89
-0.89 (-0.58%)
Jan 31, 2025, 7:14 PM BST

Neurocrine Biosciences Revenue

Neurocrine Biosciences had revenue of $622.10M USD in the quarter ending September 30, 2024, with 24.72% growth. This brings the company's revenue in the last twelve months to $2.24B, up 25.72% year-over-year. In the year 2023, Neurocrine Biosciences had annual revenue of $1.89B with 26.76% growth.

Revenue (ttm)
$2.24B
Revenue Growth
+25.72%
P/S Ratio
n/a
Revenue / Employee
$1.60M
Employees
1,400
Market Cap
12.37B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.89B398.40M26.76%
Dec 31, 20221.49B355.20M31.34%
Dec 31, 20211.13B87.60M8.38%
Dec 31, 20201.05B257.80M32.71%
Dec 31, 2019788.10M336.90M74.67%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 38.20B
GSK plc 31.31B
Haleon 11.24B
Smith & Nephew 4.46B
Hikma Pharmaceuticals 2.39B
ConvaTec Group 1.74B
HUTCHMED (China) 483.31M
Oxford Nanopore Technologies 167.75M
Revenue Rankings